Inventor · disambiguated record
Joel Richard
Also filed as: RICHARD JOEL · RICHARD JOEL FRANCOIS · RICHARD JOëL
39 granted patents·19 pending applications·723 citations·filing 1988–2024
98Inventor score
Files withRHONE POULENC CHIMIE7IPSEN PHARMA SAS6PROLABO SA5BRITANNIA PHARMACEUTICALS LTD4ARICEUM THERAPEUTICS GMBH3
Top patents by PatentIndex Score
58 records- 0186US6967028B2Prolonged release microspheres for injectable administrationETHYPHARM LAB PROD ETHIQUES·Filed 2001·Granted Nov 22, 2005·32 cites·26 claims
- 0286US5357502ADevice for the reception of digital data time frequency interlacing, notably for radio broadcasting at high bit rate towards mobile receivers with nyquist temporal windowFRANCE TELECOM AND TELEDIFFUSI·Filed 1993·Granted Oct 18, 1994·168 cites·10 claims
- 0384US6338838B1Photostable cosmetic light screening compositionsROCHE VITAMINS INC·Filed 2000·Granted Jan 15, 2002·30 cites·29 claims
- 0482US5716855AFluorescent latex containing at least two fluorochromes, process for producing it and application thereofPROLABO SA·Filed 1994·Granted Feb 10, 1998·69 cites·19 claims
- 0582US5607864AFluorescent latices having very low detection thresholds for fluorescent emissionPROLABO SA·Filed 1994·Granted Mar 4, 1997·58 cites·23 claims
- 0681US11026938B2Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2014·Granted Jun 8, 2021·2 cites·20 claims
- 0781US6183783B1Method for preparing microcapsules comprising active materials coated with a polymer and novel microcapsules in particular obtained according to the methodMAINLAB·Filed 1997·Granted Feb 6, 2001·64 cites·20 claims
- 0881US5872189AWater-redispersible powders of film-forming polymers with a "core/shell" structureRHONE POULENC CHIMIE·Filed 1995·Granted Feb 16, 1999·60 cites·17 claims
- 0979US8637021B2Formulations for TACI-immunoglobulin fusion proteinsDEL RIO ALESSANDRA·Filed 2008·Granted Jan 28, 2014·5 cites·21 claims
- 1073US11766431B2Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2021·Granted Sep 26, 2023·0 cites·18 claims
- 1171US5814407AGlycosylated particle of latex or of inorganic oxide and process for the preparation thereofPROLABO SA·Filed 1995·Granted Sep 29, 1998·30 cites·11 claims
- 1267US10543249B2Pharmaceutical composition for a sustained release of lanreotideIPSEN PHARMA SAS·Filed 2014·Granted Jan 28, 2020·1 cites·7 claims
- 1364US5795719ABiotinylated latex microsphere, process for the preparation of such a microsphere and use as agent for biological detectionPROLABO SA·Filed 1995·Granted Aug 18, 1998·26 cites·35 claims
- 1462US2010261887A1Taci-immunoglobulin fusion proteins for treatment of relapsing multiple sclerosisARES TRADING SA·Filed 2008·Application pending·0 cites
- 1561US2024366810A1Composition containing a somatostatin analogue for radiopharmaceutical useARICEUM THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 1660US9415012B2Sustained-release composition containing peptides as active ingredientRICHARD JOëL·Filed 2012·Granted Aug 16, 2016·2 cites·18 claims
- 1759US8057823B2Lipid nanocapsules, preparation process and use as medicineHEURTAULT BEATRICE·Filed 2001·Granted Nov 15, 2011·10 cites·18 claims
- 1858US5618879AAqueous dispersions of functional graft polyorganosiloxanes and curable silicone compositions comprised thereofRHONE POULENC CHIMIE·Filed 1996·Granted Apr 8, 1997·22 cites·24 claims
- 1958US2009191135A1Methods for the dispersion of water-soluable or hydrophilic substances in a supercritically pressurized fluidETHYPHARM CT NAT DE LA RECH SC·Filed 2009·Application pending·0 cites
- 2057US11969484B2Composition containing a somatostatin analogue for radiopharmaceutical useARICEUM THERAPEUTICS GMBH·Filed 2019·Granted Apr 30, 2024·0 cites·19 claims
- 2156US9138403B2PEG-interferon-beta formulationsDEL RIO ALESSANDRA·Filed 2008·Granted Sep 22, 2015·0 cites·29 claims
- 2255US6224981B1Water-redispersible powders of film-forming polymers having a core/shell structureRHODIA CHIMI·Filed 1996·Granted May 1, 2001·18 cites·32 claims
- 2355US2018098981A1Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 2453US2014056977A1Solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate and polymorphs thereofMONDOLY NATHALIE·Filed 2013·Application pending·0 cites
- 2552US5767206AUse, as antiadhesives agent and/or water repellents, of grafted functionalized polyorganosiloxanesRHONE POULENC CHIMIE·Filed 1997·Granted Jun 16, 1998·18 cites·17 claims
- 2651US8664369B2LH liquid formulationsAGOSTINETTO RITA·Filed 2008·Granted Mar 4, 2014·0 cites·15 claims
- 2751US2016310480A1Therapeutical composition containing apomorphine as active ingredientBRITANNIA PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 2850US12329830B2Composition containing a somatostatin analogue for radiopharmaceutical useARICEUM THERAPEUTICS GMBH·Filed 2019·Granted Jun 17, 2025·0 cites·21 claims
- 2950US6431958B1Method for mechanochemical treatment of a materialVIRSOL·Filed 1999·Granted Aug 13, 2002·16 cites·20 claims
- 3050US2010239580A1Taci-immunoglobulin fusion proteins for treatment of optic neuritisAREA TRADING S A·Filed 2008·Application pending·0 cites
- 3149US5901174AEqualizer-combiner for diversity receiver, receiver incorporating same and corresponding diversity reception methodALCATEL TELSPACE·Filed 1997·Granted May 4, 1999·17 cites·11 claims
- 3249US2017143834A1Formulation for hgh and rhigf-1 combinationIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
- 3348US9272020B2IFN-beta compositions, preparation methods and uses thereofLEBLANC DANIEL·Filed 2012·Granted Mar 1, 2016·0 cites·10 claims
- 3448US6680966B2Spread-spectrum transmission system with filtered multi-carrier modulationCIT ALCATEL·Filed 1999·Granted Jan 20, 2004·22 cites·5 claims
- 3548US6531217B1Polymer filaments used as a thermoluminescent dosimeterMAINELAB·Filed 2000·Granted Mar 11, 2003·8 cites·17 claims
- 3648US5976426ALatex of calibrated monodisperse magnetizable microspheres, process of preparation and use of the said latex in chemistry or in biologyPROLABO SA·Filed 1996·Granted Nov 2, 1999·13 cites·13 claims
- 3747US5331056AElectroconductive polymer compositions produced from polymerizable amphiphilic heterocyclesRHONE POULENC FILMS·Filed 1992·Granted Jul 19, 1994·7 cites·25 claims
- 3846US2012270782A1Formulation for hgh and rhigf-1 combinationGOPINATH ENONA·Filed 2010·Application pending·0 cites
- 3946US2009238865A1Lipid nanocapsules, preparation process and use as medicineMAINELAB·Filed 2009·Application pending·0 cites
- 4045US2006258798A1Methods for the dispersion of water-soluble of hydrophilic substances in a supercritically pressurized fluidETHYPHARM CT NAT DE LA RECH SC·Filed 2004·Application pending·0 cites
- 4145US2015157719A1Aqueous Gelling Compositions of Soluble Active Pharmaceutical Peptides Providing Modified ReleaseIPSEN PHARMA SAS·Filed 2013·Application pending·0 cites
- 4244US7354514B2Method for isolating and drying microparticles (microspheres or microcapsules) initially dispersed or suspensed in liquid phaseETHYPHARM SA·Filed 2001·Granted Apr 8, 2008·0 cites·22 claims
- 4344US2005133764A1Latex dispersions containing a hydroxyl functional group and a carboxylic functional group and their use for the manufacture of coatingsFiled 2005·Application pending·0 cites
- 4443US5968667ATransparencies for electrostatic reprographyRHONE POULENC FILMS·Filed 1998·Granted Oct 19, 1999·8 cites·26 claims
- 4542US6124416AAqueous emulsion of (CO) polymer made from monomer containing isocyanate group and olefinic double bondRHONE POULENC CHIMIE·Filed 1999·Granted Sep 26, 2000·5 cites·19 claims
- 4641US5908907AAqueous emulsion of (co)polymer made from monomer containing isocyanate group and olefinic double bondRHONE POULENC CHIMIE·Filed 1993·Granted Jun 1, 1999·4 cites·12 claims
- 4741US2015004210A1Sustained release formulations comprising gnrh analoguesIPSEN PHARMA SAS·Filed 2014·Application pending·0 cites
- 4840US2017035884A1Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified releaseIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
- 4939US2008193545A1Use of Glycerol Dipalmitostearate for Improving the Bioavailability of Protein Active Ingredients in Subcutaneous or Intramuscular Injectable FormulationsETHYPHARM SA·Filed 2005·Application pending·0 cites
- 5038US2016184386A1Aqueous sustained release compositions of lhrh analoguesIPSEN PHARMA SAS·Filed 2014·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →